Literature DB >> 21111940

Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: a study of 20 patients.

A Riera-Mestre1, S Martínez-Yelamos, A Martínez-Yelamos, I Ferrer, R Pujol, A Vidaller.   

Abstract

BACKGROUND: To describe the clinical characteristics and evolution of a series of adult patients hospitalized for neuro-Behçet disease (NBD).
METHODS: Consecutive patients admitted for NBD in a teaching hospital were retrospectively selected. Disability at discharge and during follow-up was graded with the modified Rankin Scale, and outcome classified as good or poor (grades 3-6).
RESULTS: Twenty patients were included (M/F, 13/7). Mean age at NBD diagnosis was 36.3 years. Nineteen patients had other manifestations of Behçet disease (BD) before NBD developed, but only 7 met the complete diagnostic criteria for BD. Fever, headache, motor weakness, and cranial nerve palsy were each present in approximately 60% of patients. There was a low prevalence of behavioral changes (5%), seizures (5%), and sphincter incontinence (0%), and a relatively high prevalence of meningism (25%). Non-neurologic manifestations of BD were concurrently detected in 15 patients (75%). 80% had parenchymal involvement. Brain biopsies during 5 attacks showed perivascular lymphocytic infiltration with reactive astrocytosis, but no frank vasculitis. During a mean follow-up of 6.3 years per patient, 12 had at least one relapse. In total, there were 22 relapses; all but two were in the same location and were symptomatically similar in each patient. At the end of follow-up, 7 patients (35%) had a poor outcome, including 4 who died.
CONCLUSION: Recording of previous manifestations of BD and a physical examination to detect concomitant systemic manifestations of BD may help establish an early diagnosis of NBD. Relapses frequently occurred in the same location. No frank vasculitis was present in brain biopsies.
Copyright © 2010 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21111940     DOI: 10.1016/j.ejim.2010.08.003

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  6 in total

Review 1.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

Review 2.  Headache in Behçet's syndrome: review of literature and NYU Behçet's syndrome center experience.

Authors:  Vijay Vishwanath; Ericka Wong; Sara C Crystal; Matthew S Robbins; Maria Filopoulos; Richard B Lipton; Yusuf Yazici; Ilya Kister
Journal:  Curr Pain Headache Rep       Date:  2014-09

3.  Clinical and Pathological Manifestations with Differential Diagnosis in Behçet's Disease.

Authors:  Aysin Kokturk
Journal:  Patholog Res Int       Date:  2011-11-28

4.  The Clinical Features and Risk Factors of Parenchymal Neuro-Behcet's Disease.

Authors:  Dong Yan; JinJing Liu; Yuehua Zhang; Wei Yuan; Yan Xu; Jing Shi; Chaoran Li; Yining Wang; Linyi Peng; Yunjiao Yang; Jiaxin Zhou; Di Wu; Zhichun Liu; Xiaofeng Zeng; Fengchun Zhang; Wenjie Zheng; Yan Zhao
Journal:  J Immunol Res       Date:  2019-09-12       Impact factor: 4.818

5.  Cerebral Venous Thrombosis in Behçet's Disease Patients Compared to Other Causes of Cerebral Venous Thrombosis: a Retrospective Study.

Authors:  Mine Hayriye Sorgun; Sefer Rzayev; Mustafa Aykut Kural; Seyda Erdoğan; Canan Yücesan
Journal:  Arch Rheumatol       Date:  2016-05-17       Impact factor: 1.472

6.  Clinical characteristics and prognosis of Neuro-Behçet's disease.

Authors:  Mine Hayriye Sorgun; Mustafa Aykut Kural; Canan Yücesan
Journal:  Eur J Rheumatol       Date:  2018-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.